Networth Advisors
DGX icon

Networth Advisors’s Quest Diagnostics DGX Stock Holding History

Networth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$115K Buy
493
+2
+0.4% +$462 0.07% 75
2026
Q2 		$104K Hold
491
– – 0.06% 76
2026
Q1 		$96.2K Hold
491
– – 0.07% 72
2025
Q4 		$85.2K Buy
+491
New +$89.4K 0.06% 71

Other funds holding DGX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Networth Advisors's DGX Position: Q3 2026 in Review

Networth Advisors increased its Quest Diagnostics (DGX) stake by 0.41% in Q3 2026, buying an estimated $462 and bringing the position to 493 shares worth $115K. The position accounts for 0.07% of the portfolio, ranked #75.

Networth Advisors first reported a position in DGX in Q4 2025 and has held it in 4 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Networth Advisors held 493 shares of Quest Diagnostics worth $115K as of Q3 2026.
  • Networth Advisors bought 2 Quest Diagnostics shares in Q3 2026, an estimated $462.
  • Quest Diagnostics made up 0.07% of Networth Advisors's portfolio in Q3 2026, its #75 holding.
  • Networth Advisors first reported a position in Quest Diagnostics in Q4 2025 and has held it in 4 quarters since.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Networth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.